326 related articles for article (PubMed ID: 29483040)
1. Pharmacodynamic assessment of diuretic efficacy and braking in a furosemide continuous infusion model.
Adin D; Atkins C; Papich MG
J Vet Cardiol; 2018 Apr; 20(2):92-101. PubMed ID: 29483040
[TBL] [Abstract][Full Text] [Related]
2. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs.
Adin DB; Taylor AW; Hill RC; Scott KC; Martin FG
J Vet Intern Med; 2003; 17(5):632-6. PubMed ID: 14529128
[TBL] [Abstract][Full Text] [Related]
3. Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs.
Adin D; Atkins C; Wallace G; Klein A
J Vet Intern Med; 2021 May; 35(3):1245-1254. PubMed ID: 33713485
[TBL] [Abstract][Full Text] [Related]
4. Furosemide continuous rate infusion diluted with 5% dextrose in water or hypertonic saline in normal adult dogs: a pilot study.
Adin D; Atkins C; Papich M; DeFrancesco T; Griffiths E; Penteado M; Kurtz K; Klein A
J Vet Cardiol; 2017 Feb; 19(1):44-56. PubMed ID: 27840084
[TBL] [Abstract][Full Text] [Related]
5. Furosemide continuous rate infusion in the horse: evaluation of enhanced efficacy and reduced side effects.
Johansson AM; Gardner SY; Levine JF; Papich MG; LaFevers DH; Fuquay LR; Reagan VH; Atkins CE
J Vet Intern Med; 2003; 17(6):887-95. PubMed ID: 14658727
[TBL] [Abstract][Full Text] [Related]
6. Differences in the duration of diuretic effects and impact on the renin-angiotensin-aldosterone system of furosemide in healthy dogs.
Hori Y; Ohshima N; Kanai K; Hoshi F; Itoh N; Higuchi S
J Vet Med Sci; 2010 Jan; 72(1):13-8. PubMed ID: 19893284
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the effects of torsemide and furosemide on the renin-angiotensin-aldosterone system of normal dogs.
Potter BM; Ames MK; Hess A; Poglitsch M
J Vet Cardiol; 2019 Dec; 26():51-62. PubMed ID: 31809955
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.
Lantis AC; Ames MK; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
J Vet Pharmacol Ther; 2015 Feb; 38(1):65-73. PubMed ID: 25224804
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
10. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
Lantis AC; Ames MK; Werre S; Atkins CE
J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
[TBL] [Abstract][Full Text] [Related]
11. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
12. Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs.
Lantis AC; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
Am J Vet Res; 2011 Dec; 72(12):1646-51. PubMed ID: 22126693
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats.
Roche-Catholy M; Paepe D; Devreese M; Broeckx BJG; Woehrlé F; Schneider M; de Salazar Alcala AG; Hellemans A; Smets P
J Vet Intern Med; 2022 Sep; 36(5):1782-1791. PubMed ID: 35906901
[TBL] [Abstract][Full Text] [Related]
14. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
[TBL] [Abstract][Full Text] [Related]
15. Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs.
Hori Y; Katou A; Tsubaki M; Kanai K; Nakao R; Hoshi F; Itoh N; Higuchi S
Am J Vet Res; 2008 Dec; 69(12):1664-9. PubMed ID: 19046016
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the diuretic effect of furosemide by different methods of administration in healthy dogs.
Harada K; Ukai Y; Kanakubo K; Yamano S; Lee J; Kurosawa TA; Uechi M
J Vet Emerg Crit Care (San Antonio); 2015; 25(3):364-71. PubMed ID: 25885944
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Ames MK; Atkins CE; Eriksson A; Hess AM
J Vet Cardiol; 2017 Jun; 19(3):218-227. PubMed ID: 28576479
[TBL] [Abstract][Full Text] [Related]
18. Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology.
Mochel JP; Fink M; Peyrou M; Desevaux C; Deurinck M; Giraudel JM; Danhof M
Chronobiol Int; 2013 Nov; 30(9):1144-59. PubMed ID: 23931032
[TBL] [Abstract][Full Text] [Related]
19. Hormonal response to acute diuresis--a comparative study of furosemide and azosemide.
Ogawa K; Hatano T; Yamamoto M; Matsui N
Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):284-90. PubMed ID: 6378806
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion profile of torasemide and its diuretic action in dogs.
Sogame Y; Okano K; Hayashi K; Uchida T; Tsuda Y
J Pharm Pharmacol; 1996 Apr; 48(4):375-9. PubMed ID: 8794986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
